Navidea wins SBIR grant; Alcohol abuse and eating disorders share genetic link;

@FierceBiotech: Popular yesterday: Novartis wins a record breakthrough therapy designation for orphan drug. Article | Follow @FierceBiotech

@JohnCFierce: Just came across my story on first IPO of '13 - $STML, priced at $10, now $34.55. Hopeful signs, indeed. Article | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotechResearchReport | Follow @EmilyMFierce

> Navidea Biopharmaceuticals ($NAVB) says it won a Small Business Innovation Research (SBIR) grant from the National Institute On Aging in connection with the Phase III clinical program for its NAV4694 beta-amyloid imaging agent for Alzheimer's. Release

> A Taiwan-based biotech startup dubbed TaiGen Biotechnology is being listed on a local exchange. Yuen Goong Yu Group, a paper manufacturer, is launching the company. Story

Medical Device News

@FierceMedDev: Popular this week: Inventor launches crowdfunding hub for medical devices. Article | Follow @FierceMedDev

@DamianFierce: Finally, some good news for Navidea: Medicare expansion and a Siemens partnership. Report | Follow @DamianFierce

@MarkHFierce: In 2012, medical device employment at the top companies mostly grew, due to M&A and organic growth. ICYM the feature | Follow @MarkHFierce

> Boston Scientific wins FDA nods for electrophysiology tech. More

> Medtronic's Ishrak outlines health services expansion plans. Article

> Quest dumps $1B into repurchase plan as sales ail. Story

> Acutus Medical closes $28M round for arrhythmia mapping device. Item

Pharma News

@FiercePharma: Novartis picks Dublin site for new regional business center, on track for 100 new jobs there. More | Follow @FiercePharma

@EricPFierce: Alexion recalls some Soliris in EC "due to the presence of visible particles in a limited number of vials." More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Shire enlists help fighting unwanted takeover. Another co. seeking access to Ireland's tax regime? Popular yesterday from FiercePharma | Follow @CarlyHFierce

> China's pharma probe intensifies with British consultant's arrest. More

> India's Biocon promises Herceptin biosim launch by fiscal year-end. Article

> Allergan pushes FDA to defend Restasis from early generics. Report

Biomarkers News

> Blood samples may aid suicide risk prediction. Story

> Possible psychosis biomarker found in brain 'folding.' Story

> Potential Alzheimer's biomarker targeted in brain fluid. More

> Lung cancer gene variants could help boost survival odds. Article

> Biomarker gauges graft-versus-host disease risk for stem cell transplant patients. Item

Drug Delivery News

@MichaelGFierce: Time-release delivery of vision-loss drug demands fewer injections. More | Follow @MichaelGFierce

> Study: Insulin pumps improve glycemic control in children with diabetes. Story

> Bind launches second PhII trial for prostate cancer nanomed. More

> Alnylam wins two orphan designations for hemophilia RNAi drug. Report

> Platinum-based radiotherapy method zaps cancer with nanomeds. Article

And Finally… Researchers at Washington University School of Medicine say that alcohol abuse and eating disorders share some common genetic links. Story

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.